Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 11:52AM ET
7.97
Dollar change
+0.17
Percentage change
2.18
%
IndexRUT P/E- EPS (ttm)-3.93 Insider Own17.24% Shs Outstand38.38M Perf Week0.76%
Market Cap305.89M Forward P/E- EPS next Y-2.77 Insider Trans0.01% Shs Float31.76M Perf Month17.21%
Income-90.25M PEG- EPS next Q-0.65 Inst Own78.12% Short Float9.60% Perf Quarter-13.93%
Sales0.00M P/S- EPS this Y43.56% Inst Trans-0.60% Short Ratio6.65 Perf Half Y6.13%
Book/sh5.57 P/B1.43 EPS next Y-1.56% ROA-37.74% Short Interest3.05M Perf Year70.30%
Cash/sh5.37 P/C1.48 EPS next 5Y- ROE-45.75% 52W Range1.81 - 15.05 Perf YTD29.80%
Dividend Est.- P/FCF- EPS past 5Y32.21% ROI-38.51% 52W High-47.04% Beta1.85
Dividend TTM- Quick Ratio14.94 Sales past 5Y-28.11% Gross Margin- 52W Low340.33% ATR (14)0.87
Dividend Ex-Date- Current Ratio14.94 EPS Y/Y TTM52.93% Oper. Margin0.00% RSI (14)53.31 Volatility14.16% 11.94%
Employees88 Debt/Eq0.12 Sales Y/Y TTM-100.00% Profit Margin- Recom1.11 Target Price18.57
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q58.55% Payout- Rel Volume0.34 Prev Close7.80
Sales Surprise-100.00% EPS Surprise0.03% Sales Q/Q- EarningsMay 09 Avg Volume458.12K Price7.97
SMA2015.68% SMA501.38% SMA20011.32% Trades Volume61,479 Change2.18%
Date Action Analyst Rating Change Price Target Change
Jul-15-24Upgrade JP Morgan Neutral → Overweight $10 → $15
Jun-24-24Upgrade Leerink Partners Market Perform → Outperform $12
May-31-24Resumed Piper Sandler Overweight $20
Mar-28-24Initiated William Blair Outperform $40
Mar-15-24Initiated Citigroup Buy $16
Mar-14-24Upgrade Piper Sandler Neutral → Overweight $8 → $20
Dec-08-23Initiated H.C. Wainwright Buy $9
Jul-12-21Initiated Piper Sandler Neutral $6
May-27-21Initiated Jefferies Buy $7
Mar-16-21Upgrade SVB Leerink Mkt Perform → Outperform $3 → $15
Jul-01-24 04:19PM
08:00AM
Jun-21-24 07:52AM
Jun-04-24 04:00PM
May-20-24 06:00AM
12:53PM Loading…
May-15-24 12:53PM
07:52AM
May-07-24 07:00AM
May-02-24 04:05PM
Apr-03-24 04:05PM
Apr-02-24 10:35AM
07:20AM
Apr-01-24 07:45AM
Mar-28-24 04:08PM
Mar-27-24 07:00AM
07:44AM Loading…
Mar-13-24 07:44AM
Mar-07-24 07:00AM
Mar-06-24 08:00AM
Feb-29-24 03:02AM
Jan-17-24 11:27AM
Jan-16-24 01:10PM
08:00AM
Jan-15-24 10:18AM
Jan-08-24 07:09AM
Jan-04-24 08:00AM
Dec-08-23 05:37AM
Dec-07-23 08:00AM
Nov-22-23 08:00AM
Nov-16-23 08:29AM
Nov-14-23 04:05PM
08:00AM Loading…
Nov-09-23 08:00AM
Nov-08-23 04:17PM
Oct-02-23 08:00AM
Sep-20-23 08:00AM
Sep-05-23 08:56AM
Aug-31-23 08:00AM
Aug-14-23 04:17PM
Jun-01-23 08:00AM
May-22-23 08:00AM
May-16-23 08:00AM
May-11-23 09:35AM
07:30AM
May-08-23 04:05PM
Apr-21-23 08:00AM
Apr-20-23 10:03AM
Apr-19-23 10:01AM
Apr-13-23 08:00AM
Mar-25-23 09:44AM
Mar-23-23 08:00AM
Mar-21-23 08:00AM
Mar-07-23 08:00AM
Mar-02-23 07:52AM
Feb-08-23 08:00AM
Jan-26-23 08:00AM
Jan-11-23 08:00AM
Jan-10-23 08:00AM
Jan-09-23 04:26PM
08:01AM
08:00AM
Dec-05-22 04:35PM
07:30AM
Dec-01-22 04:15PM
Nov-22-22 08:00AM
Nov-10-22 08:55AM
07:34AM
Nov-08-22 06:25PM
Nov-01-22 07:55AM
Oct-27-22 10:02AM
08:00AM
Oct-26-22 10:02AM
Oct-20-22 02:41PM
Oct-17-22 11:30AM
08:00AM
Oct-13-22 08:00AM
Oct-03-22 05:32AM
Sep-30-22 07:00AM
Sep-29-22 08:00AM
Aug-14-22 08:07AM
Aug-13-22 08:06AM
Aug-11-22 09:15AM
07:53AM
Jul-14-22 08:13AM
Jun-23-22 08:00AM
Jun-02-22 08:30AM
08:00AM
May-17-22 08:00AM
May-02-22 09:29AM
Apr-28-22 01:38PM
Apr-27-22 10:35AM
07:30AM
Apr-25-22 08:00AM
Apr-07-22 08:23AM
Apr-05-22 02:20PM
09:25AM
Apr-04-22 10:40AM
Mar-14-22 09:35AM
08:09AM
Feb-10-22 08:00AM
Feb-04-22 10:14AM
Jan-10-22 08:00AM
Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kahn ClareDirectorJun 07 '24Buy7.671,1008,4421,100Jun 11 02:15 PM
Ganot IlanDirectorMay 02 '24Sale10.334624,7729,507May 06 06:48 PM
Ganot IlanDirectorJan 29 '24Sale7.991391,1118,416Jan 30 05:20 PM
PERCEPTIVE ADVISORS LLCDirectorJan 11 '24Buy5.533,410,71318,861,2436,833,539Jan 12 05:15 PM
RA CAPITAL MANAGEMENT, L.P.DirectorJan 11 '24Buy5.53904,1605,000,0054,192,216Jan 12 05:01 PM
Tan KevinCFO & TreasurerJan 09 '24Sale8.203,93532,2679,308Jan 11 05:43 PM
Ganot IlanDirectorJan 03 '24Sale5.301,1426,0528,167Jan 05 07:04 PM
Cumbo AlexanderPresident and CEODec 04 '23Sale2.7711,75732,51617,439Dec 05 02:40 PM
Howton David TChief Operating OfficerDec 04 '23Sale2.785,36714,9207,684Dec 05 02:32 PM
Hanrahan JessieChief Regulatory OfficerDec 04 '23Sale2.784,87913,5626,983Dec 05 02:30 PM
Marlowe JenniferCSODec 04 '23Sale2.774,89013,5256,998Dec 05 02:30 PM
Herzich PaulChief Technology OfficerDec 04 '23Sale2.772,9688,2324,270Dec 05 02:31 PM